) Omjjara (momelotinib), discovered by Melbourne scientists in 2005, is now available on the PBS to treat the rare bone marrow cancer myelofibrosis. 1,2 This is the first time in almost a decade that eligible patients with this debilitating bone marrow cancer have an approved and PBS reimbursed new treatment option. 1-3... read full story